HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Sells $11,053.96 in Stock

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) major shareholder Of America Corp /De/ Bank sold 412 shares of the stock in a transaction that occurred on Tuesday, April 3rd. The stock was sold at an average price of $26.83, for a total value of $11,053.96. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.

HCA Healthcare Price Performance

HCA traded up $0.31 during trading on Tuesday, reaching $345.86. The stock had a trading volume of 1,226,315 shares, compared to its average volume of 1,348,308. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock has a 50 day moving average of $325.79 and a two-hundred day moving average of $340.25. The firm has a market capitalization of $85.15 billion, a price-to-earnings ratio of 15.74, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the firm earned $5.90 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

Remove Ads

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare's payout ratio is presently 13.11%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in HCA. MML Investors Services LLC lifted its holdings in shares of HCA Healthcare by 31.7% in the third quarter. MML Investors Services LLC now owns 17,816 shares of the company's stock valued at $7,241,000 after purchasing an additional 4,285 shares in the last quarter. Meritage Group LP purchased a new position in HCA Healthcare during the 3rd quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter worth approximately $18,044,000. NRI Wealth Management LC purchased a new position in HCA Healthcare during the fourth quarter valued at approximately $2,896,000. Finally, Czech National Bank lifted its position in HCA Healthcare by 4.5% in the 4th quarter. Czech National Bank now owns 39,543 shares of the company's stock worth $11,869,000 after buying an additional 1,691 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on HCA shares. Royal Bank of Canada decreased their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a report on Monday, January 27th. KeyCorp lowered their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research report on Tuesday, January 7th. Barclays decreased their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research note on Monday, January 27th. Bank of America cut their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a report on Monday, January 27th. Finally, Morgan Stanley dropped their target price on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a research report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.